Skip to main content

GSA CAPITAL PARTNERS LLP

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1362033 LONDON, X0

Position in HRTX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$448,443
+$364,392 QoQ
Shares Held
1,042,892
+892.6% QoQ
Ownership
0.549%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#25
of 160 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. HRTX ranks #82 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HRTX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $448,443 1,042,892
2026-03-31 $84,051 105,064
2025-12-31 $175,615 135,089
2025-09-30 $126,228 100,181
2025-06-30 $615,454 297,321
2024-09-30 $1,020,344 512,736
2024-06-30 $1,515,696 433,056
2024-03-31 $774,766 279,699
2023-12-31 $577,061 339,448
2023-03-31 $97,437 64,528
2022-12-31 $291,435 116,574
2022-09-30 $364,856 86,459
2022-06-30 $561,972 201,424
2022-03-31 $848,115 148,272
2021-12-31 $313,834 34,374
2021-09-30 $389,564 36,442
2021-06-30 $932,643 60,093
2021-03-31 $540,911 33,369
2020-09-30 $625,063 42,177
2020-03-31 $474,988 40,459